MM_Hub: CONGRESS|#EHA 2021|Mounzer Agha presented initial results of CARTITUDE-2 for cilta-cel safety & efficacy for pts with multiple myeloma. Pts receiving 1–3 prior lines of therapy had early & deep responses with manageable safety.#mmsm, #myeloma, @PittTweet,

by | Jun 11, 2021 | Twitter | 0 comments

CONGRESS|#EHA 2021|Mounzer Agha presented initial results of CARTITUDE-2 for cilta-cel safety & efficacy for pts with multiple myeloma. Pts receiving 1–3 prior lines of therapy had early & deep responses with manageable safety.#mmsm, #myeloma, @PittTweet, https://t.co/oInyAFQS47 pic.twitter.com/u004v8M0BI

— Multiple Myeloma Hub (@MM_Hub) June 11, 2021

Submit a Comment